scholarly article | Q13442814 |
P356 | DOI | 10.1097/01.ALC.0000099264.36220.48 |
P698 | PubMed publication ID | 14691376 |
P2093 | author name string | Lawrence D Middaugh | |
Peter W Kalivas | |||
Karen K Szumlinski | |||
Angela-Leigh Bandy Marlowe | |||
Yancy Van Patten | |||
P2860 | cites work | Effects of Ro 15-4513 on ethanol discrimination in C57BL/6 mice | Q33235377 |
Strategies for understanding the pharmacological effects of ethanol with drug discrimination procedures | Q33748903 | ||
Drugs of abuse: behavioural principles, methods and terms | Q36208817 | ||
Drugs of abuse: anatomy, pharmacology and function of reward pathways | Q36208822 | ||
Ethanol consumption and taste preferences in C57BL/6ByJ and 129/J mice | Q36800702 | ||
Role of taste and calories in the selection of ethanol by C57BL/6NHsd and Hsd:ICR mice | Q38552590 | ||
Catecholamine theories of reward: A critical review | Q39759474 | ||
Brain substrates for reinforcement and drug self-administration | Q40328739 | ||
Ethanol increases extracellular dopamine concentration in the ventral striatum in C57BL/6 mice | Q42445049 | ||
Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice | Q44330033 | ||
Effects of ethanol on mature offspring of mice given ethanol during pregnancy | Q45371004 | ||
Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCepsilon-deficient mice. | Q46034941 | ||
Comparison of the discriminative stimulus function of ethanol following intracranial and systemic administration: evidence of a central mechanism. | Q48158545 | ||
Long-term intracranial cannula stabilization in mice with light cured resin composites | Q48494518 | ||
Voluntary alcohol consumption in BXD recombinant inbred mice: relationship to alcohol metabolism | Q49146883 | ||
Discriminative stimulus effects of ethanol and 3 alpha-hydroxy-5 alpha-pregnan-20-one in relation to menstrual cycle phase in cynomolgus monkeys (Macaca fascicularis). | Q51547218 | ||
Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice. | Q52164502 | ||
The discrimination and durability of an ethanol cue in young and mid-aged female mice. | Q52196020 | ||
Alcohol consumption by C57BL/6, BALB/c, and DBA/2 mice in a limited access paradigm. | Q52272769 | ||
Gender differences in the effects of ethanol on C57BL/6 mice | Q68156601 | ||
Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL/6 and DBA/2 mice | Q71901313 | ||
Brain microdialysis in the mouse | Q72184694 | ||
Voluntary consumption of ethanol in 15 inbred mouse strains | Q72579770 | ||
Localization of genes affecting alcohol drinking in mice | Q72851369 | ||
Ethanol consumption by C57BL/6 mice: influence of gender and procedural variables | Q77409190 | ||
P433 | issue | 12 | |
P921 | main subject | dopamine | Q170304 |
naltrexone | Q409587 | ||
P304 | page(s) | 1892-1900 | |
P577 | publication date | 2003-12-01 | |
P1433 | published in | Alcoholism: Clinical and Experimental Research | Q4713331 |
P1476 | title | Chronic ethanol consumption by C57BL/6 mice promotes tolerance to its interoceptive cues and increases extracellular dopamine, an effect blocked by naltrexone | |
P478 | volume | 27 |
Q37732461 | "Drinking in the dark" (DID) procedures: a model of binge-like ethanol drinking in non-dependent mice |
Q44341058 | A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence |
Q46796125 | A phenotype-driven ENU mutagenesis screen for the identification of dominant mutations involved in alcohol consumption. |
Q46375977 | A procedure to produce high alcohol intake in mice |
Q37398767 | Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice |
Q46032431 | Accumbens neurochemical adaptations produced by binge-like alcohol consumption. |
Q28286555 | Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice |
Q43254015 | Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice. |
Q34013720 | Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control |
Q34415017 | Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking |
Q36675748 | Chronic voluntary alcohol consumption results in tolerance to sedative/hypnotic and hypothermic effects of alcohol in hybrid mice |
Q46933537 | Development of a mouse model of ethanol addiction: naltrexone efficacy in reducing consumption but not craving |
Q36824245 | Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people |
Q89894281 | Effects of naltrexone on alcohol, sucrose, and saccharin binge-like drinking in C57BL/6J mice: a study with a multiple bottle choice procedure |
Q36672572 | GABAergic modulation of binge-like ethanol intake in C57BL/6J mice |
Q48388258 | Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats |
Q46679048 | Habituation to test procedure modulates the involvement of dopamine D2- but not D1-receptors in ethanol-induced locomotor stimulation in mice. |
Q34578716 | Hybrid C57BL/6J x FVB/NJ mice drink more alcohol than do C57BL/6J mice |
Q45193987 | Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice |
Q34369448 | Intensity and duration of chronic ethanol exposure is critical for subsequent escalation of voluntary ethanol drinking in mice |
Q34733355 | Intermittent (every-other-day) drinking induces rapid escalation of ethanol intake and preference in adolescent and adult C57BL/6J mice |
Q36298365 | Laboratory models of alcoholism: treatment target identification and insight into mechanisms |
Q24603933 | Long-lasting alterations to DNA methylation and ncRNAs could underlie the effects of fetal alcohol exposure in mice |
Q30399592 | Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone |
Q36724460 | Longitudinal associations between smoking cessation medications and alcohol consumption among smokers in the International Tobacco Control Four Country survey |
Q35199159 | Maternal separation stress in male mice: long-term increases in alcohol intake. |
Q42662736 | Modulation of elevated plus maze behavior after chronic exposure to the anabolic steroid 17alpha-methyltestosterone in adult mice |
Q46577821 | Naloxone does not attenuate the locomotor effects of ethanol in FAST, SLOW, or two heterogeneous stocks of mice |
Q34656944 | Naltrexone for the management of alcohol dependence |
Q37638007 | Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use. |
Q50065382 | Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence |
Q38837127 | Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. |
Q36342934 | Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research |
Q44342984 | Selective mu- and kappa-opioid receptor antagonists administered into the nucleus accumbens interfere with rapid tolerance to ethanol in rats |
Q45743679 | Strain differences in alcohol-induced neurochemical plasticity: a role for accumbens glutamate in alcohol intake |
Q46605162 | Systemic and intra-accumbens microinjections of naltrexone interfere with tolerance to ethanol in rats |
Q45152841 | The dopamine D1 antagonist reduces ethanol reward for C57BL/6 mice |
Q36677469 | The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics |
Q35892525 | The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats |
Q47830362 | The neurobiology of impulse control disorders in Parkinson's disease: from neurotransmitters to neural networks. |
Q35102390 | The synaptoneurosome transcriptome: a model for profiling the emolecular effects of alcohol |
Q36848918 | The μ opioid receptor is not involved in ethanol-stimulated dopamine release in the ventral striatum of C57BL/6J mice |
Q33825408 | Varenicline reduces alcohol self-administration in heavy-drinking smokers |
Search more.